THE TAPE

Imax Corp

$46.76▼ −3.17%
Last close
Relative strength
75RS
of 99, against every stock▼ -16 on the month
Cooling off
Unconfirmed
+36.3%
six months against the S&P 500
52-week range
−19.0%
from the high
$32.71$57.73
Setup
blue skyplayed out
−15.8%
against the pivot at $55.57
No report date on the calendar.
Growth REALProof SHOWN
Quarter to Sep 30, revenue +64% on a year ago
11/16 O 47.76 H 47.88 L 46.00 Vol 1.5M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS75
vs pivot−15.85%
Tightening1.00×
Dry-up0.94×
Up/down vol-0.07
From high19%
played out1 of 9checks
Previous breakout stopped out ▼ −8.28% in Feb
Cooling off
Support and resistance
Support below
$40.88
-12.6% · tested 5× · last 84 sessions ago
Resistance above
$48.44
+3.6% · tested 3× · last 27 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 4.6 weeks and fell 10% from its ceiling at its deepest. The pivot is $55.57, and the stock closed 15.8% below it. Its relative strength rating is 75.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
-5.1%
Three months against the S&P 500
-4.1%
Six months against the S&P 500
+36.3%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same industry
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 5.4% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$484.0M
+63.7% year on year
Operating margin
26.8%
gross 63.5%
Net margin
27.7%
Free cash flow
$146.0M
5.7% of market cap
Price to sales
5.30×
Price to earnings
19.1×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 5
Key takeaway
Growth with the cash to show for it: the quarter confirms the thesis.
Revenue
$174.6M
+69.7% QoQ · +63.7% YoY
Gross margin
72.4%
+11.2 pts QoQ
Net income
$113.8M
Positive
Free cash flow
$84.2M
Cash generating

What the numbers say

  • Good: Revenue +63.7% year over year, +69.7% on the quarter
  • Good: Gross margin 72.4%, +11.2 points on the quarter
  • Good: Profitable: net income $114M, operating margin 42.9%
  • Good: Cash generating: operating cash flow $86M, free cash flow $84M
  • Good: Net cash $208M · cash $208M
Revenue by quarter
Free cash flow
Net income
shares +4.4% in a year · net cash $207.9M

What is not obvious

  • Margin quality: depreciation and amortisation $27M is 15% of revenue; gross margin 72.4% reads 57.0% if it is charged there

The desk’s own read

Flagged as drifting down since the report

Final read
Growth: REAL · Economic proof: SHOWN
Key question: Does the next quarter repeat this one?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
Closed below its 20- and 50-day on heavy volumeTape · 2026-11-11
below 20d & 50d on 1.5x volume at 48.91
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
Closed below its 20- and 50-day on heavy volumeTape · 2026-11-06
below 20d & 50d on 2.6x volume at 48.13
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
GappedTape · 2026-11-06
-7.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ down on earningsTape · 2026-11-06
-7.0% on earnings 2026-11-05
No measurable effect: stocks behave like random ones over the next three sessions (665 cases over 44 nights).
Unusual volumeTape · 2026-11-06
4.1 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Earnings comingEvent · 2026-11-04
reports 2026-11-05 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Earnings date movedEvent · 2026-10-21
2026-10-21 -> 2026-11-05
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).
Earnings date movedEvent · 2026-10-20
2026-10-22 -> 2026-10-21
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
9
$29,119,065 total

Sold: LISTER ROBERT D, WELTON MARK, Weissman Kenneth Ian, Fernandes Natasha, PABLO CALAMERA, GELFOND RICHARD L, Zlatar Jose Aleksandr.

Not counted above: 14 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-09-10 LISTER ROBERT D · Chief Legal Officer Sr Exec VPsell22,500$1,160,577
2026-08-25 WELTON MARK · President IMAX Global Theatressell30,000$1,634,208
2026-08-25 Weissman Kenneth Ian · Deputy GC, Corp. Sec. & CCOsell8,000$436,294
2026-08-24 Fernandes Natasha · Chief Financial Officer & EVPsell20,000$1,092,554
2026-08-20 PABLO CALAMERA · CTO & EVPsell15,000$786,174
2026-08-20 GELFOND RICHARD L · Chief Executive Officer, Directorsell100,000$5,323,370
2026-08-19 GELFOND RICHARD L · Chief Executive Officer, Directorconversion205,504$6,555,578
2026-08-19 GELFOND RICHARD L · Chief Executive Officer, Directorsell205,504$10,946,294

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

1 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy3
Buy7
Hold2
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray
5w · 10%

The most recent of 4 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Imax Corp (IMAX) — The Tape